WDR43 can also robustly bind to promoter-associated noncoding/nascent RNA.[11,30] However, several research studies have examined the molecular role of WDR43 up to this point.[14,25] This study conducted an all-encompassing pan-cancer analysis of WDR43 through the entire TCGA cancers to determine its possible functions and underlying pathways through the incidence, proliferation, and clinical outcomes of distinct tumors. This evidence concerns the gene WDR43 and cancer.